Corcept Therapeutics
CORT
#2849
Rank
โ‚ฌ5.08 B
Marketcap
47,35ย โ‚ฌ
Share price
-2.22%
Change (1 day)
-28.91%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2026 (TTM): โ‚ฌ0.65 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.66 Billion. In 2025 the company made a revenue of โ‚ฌ0.64 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ0.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.65 B1.27%
2025 โ‚ฌ0.64 B-0.08%
2024 โ‚ฌ0.64 B48.66%
2023 โ‚ฌ0.43 B16.48%
2022 โ‚ฌ0.37 B15.93%
2021 โ‚ฌ0.32 B12.32%
2020 โ‚ฌ0.28 B5.16%
2019 โ‚ฌ0.27 B24.57%
2018 โ‚ฌ0.21 B65.52%
2017 โ‚ฌ0.13 B71.62%
2016 โ‚ฌ77.31 M68.11%
2015 โ‚ฌ45.99 M110.66%
2014 โ‚ฌ21.83 M191.11%
2013 โ‚ฌ7.49 M199.98%
2012 โ‚ฌ2.5 M
2011 N/A
2010 N/A-100%
2009 โ‚ฌ0.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ82.77 B 12,429.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.60 B 7,256.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ54.38 B 8,132.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ62.06 B 9,294.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ56.49 B 8,451.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.64 B 6,203.89%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ0.29 B-54.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.26 B-60.50%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ2.78 B 321.57%๐Ÿ‡บ๐Ÿ‡ธ USA